Spatial Proteomics Maps Protein Aggregates in Parkinson’s Disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Spatial Proteomics Maps Protein Aggregates in Parkinson’s Disease

  • November 20, 2026

  • 3 min

Share

Objective:

To identify proteins selectively concentrated in α-synuclein inclusions, distinguishing them from proteins present in surrounding cells.

Approach:
  • Workflow: Aggregate Deep Visual Proteomics combined image-guided segmentation, laser microdissection, low-input sample preparation, and liquid chromatography–tandem mass spectrometry. Inclusion material was compared with matched host material.
  • Study systems: Researchers analyzed an A53T α-synuclein cell model, induced pluripotent stem cell-derived dopaminergic neurons, and postmortem brain tissue from donors with Parkinson’s disease or Lewy body disease.
Key Findings:
  • In the cell model, 7,290 proteins were quantified; inclusion enrichment was largely independent of cellular protein abundance.
  • Neuritic and somatic neuronal inclusions had distinct protein profiles. Neuritic inclusions were enriched in machinery associated with misfolded and ubiquitinated proteins, including a sevenfold increase in UBQLN2; somatic inclusions contained more intermediat…
  • In postmortem tissue from 16 donors, 6,842 protein groups were quantified. Lewy body-like inclusions were enriched in synaptic-vesicle proteins, SNARE machinery, and V-ATPase components relative to matched host neurons.
  • Across the three systems, 421 of 438 evaluated protein complexes showed coordinated enrichment or depletion. V-ATPase was the only complete molecular machine enriched in all three.
  • In the cell model, phosphorylated α-synuclein was approximately tenfold more abundant in inclusions than in remaining cell material; about one-third of the increase was detectable before visible inclusions formed.
Interpretation:

The study supports a model in which α-synuclein inclusions selectively sequester membrane-associated machinery and retain cargo linked to impaired degradation.

Limitations:
  • The human cohort was small.
  • Patients represented a single Lewy body stage.
  • The workflow did not resolve finer histopathological subtypes.
Sources:

Original Source(s)

Related Content